Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Growth stocks
Undervalued stocks
Trend-Following Stocks
Quality stocks
Yield stocks
ESG stocks
Investment Themes
Sin stocks
Europe's family businesses
Artificial Intelligence
Cybersecurity
Water
Fintechs
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
US Basketball
Smart City
The SPAC
Fintechs
Water
Education
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
NovoCure Limited
News
Analyst Reco.
NVCR
JE00BYSS4X48
NOVOCURE LIMITED
(NVCR)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-07-01 pm EDT
73.30
USD
+5.47%
07/01
Novocure to Report Second Quarter 2022 Financial Results
BU
06/24
NOVOCURE LIMITED(NASDAQGS
: NVCR) added to Russell 2500 Index
CI
06/24
NOVOCURE LIMITED(NASDAQGS
: NVCR) added to Russell 2500 Growth Index
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Analyst Recommendations on NOVOCURE LIMITED
06/06
HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16
HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13
Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
04/04
Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Ratin..
MT
02/08
Loop Capital Starts NovoCure at Buy With $200 Price Target
MT
02/02
Oppenheimer Upgrades NovoCure to Outperform From Perform; Price Target is $98
MT
01/20
Truist Securities Upgrades NovoCure to Buy from Hold, Keeps $125 Price Target
MT
01/11
Wells Fargo Adjusts NovoCure's Price Target to $70 From $105, Keeps Equalweight Rating
MT
01/10
Wedbush Cuts NovoCure's Price Target to $45 From $85, Says 'Revenues Have Flat-Lined;' ..
MT
01/06
Piper Sandler Adjusts NovoCure's Price Target to $130 From $180, Reiterates Overweight ..
MT
01/03
Evercore ISI Upgrades NovoCure to In-Line From Underperform; Keeps Price Target at $82
MT
2021
Wedbush Adjusts Price Target for NovoCure to $85 From $101, Maintains Underperform Rati..
MT
2021
NOVOCURE
: Wedbush Adjusts NovoCure PT to $101 From $148, Maintains Underperform Rating
MT
2021
NOVOCURE
: Wells Fargo Adjusts Price Target on NovoCure to $180 From $215, Maintains Equal..
MT
2021
NOVOCURE
: Mizuho Securities Adjusts NovoCure's Price Target to $200 From $229, Maintains ..
MT
2021
NOVOCURE
: Piper Sandler Adjusts NovoCure's Price Target to $240 From $235, Reiterates Ove..
MT
2021
NOVOCURE
: Mizuho Securities Cuts NovoCure to Neutral From Buy, Price Target to $229 From ..
MT
2021
NOVOCURE
: Wedbush Lowers NovoCure's Price Target to $148 From $154 on Optune Revenue Expe..
MT
2021
NOVOCURE
: Truist Securities Adjusts Price Target on NovoCure to $142 From $132, Maintains..
MT
2021
NOVOCURE
: JP Morgan Adjusts NovoCure PT to $172 From $103, Maintains Neutral Rating
MT
2021
NOVOCURE
: Northland Capital Adjusts NovoCure's Price Target to $250 from $200, Keeps Outp..
MT
2021
NOVOCURE
: Mizuho Adjusts NovoCure's Price Target to $242 From $175, Maintains Buy Rating
MT
2021
NOVOCURE
: Wedbush Cuts NovoCure to Underperform From Neutral, PT to $154 From $159 on Ass..
MT
2021
NOVOCURE
: Wells Fargo Adjusts NovoCure PT to $215 From $135, Maintains Equal Weight Ratin..
MT
2021
NOVOCURE
: Mizuho Adjusts Price Target on NovoCure to $175 From $150, Maintains Buy Rating
MT
2021
NOVOCURE
: Wedbush Adjusts NovoCure's Price Target to $159 From $110, Maintains Neutral Ra..
MT
Upcoming event on NOVOCURE LIMITED
07/28/22
Interim 2022 Earnings Call
Company calendar
Upcoming sector events
07/19/22
GETINGE AB
: Interim 2022 Earnings Release
07/26/22
MASIMO CORPORATION
: Interim 2022 Earnings Release (Projected)
08/04/22
IRAY TECHNOLOGY COMPANY LIMITED
: Interim 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Medical Equipment
Slave